Research ArticleCardiovascular
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies
Mami Ojima, Hideki Igata, Masayuki Tanaka, Hiroki Sakamoto, Takanobu Kuroita, Yasuhisa Kohara, Keiji Kubo, Hiromitsu Fuse, Yoshimi Imura, Keiji Kusumoto and Hideaki Nagaya
Journal of Pharmacology and Experimental Therapeutics March 2011, 336 (3) 801-808; DOI: https://doi.org/10.1124/jpet.110.176636
Mami Ojima
Hideki Igata
Masayuki Tanaka
Hiroki Sakamoto
Takanobu Kuroita
Yasuhisa Kohara
Keiji Kubo
Hiromitsu Fuse
Yoshimi Imura
Keiji Kusumoto
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies
Mami Ojima, Hideki Igata, Masayuki Tanaka, Hiroki Sakamoto, Takanobu Kuroita, Yasuhisa Kohara, Keiji Kubo, Hiromitsu Fuse, Yoshimi Imura, Keiji Kusumoto and Hideaki Nagaya
Journal of Pharmacology and Experimental Therapeutics March 1, 2011, 336 (3) 801-808; DOI: https://doi.org/10.1124/jpet.110.176636
Research ArticleCardiovascular
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies
Mami Ojima, Hideki Igata, Masayuki Tanaka, Hiroki Sakamoto, Takanobu Kuroita, Yasuhisa Kohara, Keiji Kubo, Hiromitsu Fuse, Yoshimi Imura, Keiji Kusumoto and Hideaki Nagaya
Journal of Pharmacology and Experimental Therapeutics March 1, 2011, 336 (3) 801-808; DOI: https://doi.org/10.1124/jpet.110.176636
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement